Finance

Beta
Lists
TXMD:NASDAQ
TherapeuticsMD Inc
$1.99
-0.50%
(-0.0100) 1D
$1.92
-3.52% (-0.070)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXMD...
Open
$2.01
High
$2.02
Low
$1.94
Mkt. cap
23.03M
Avg. vol.
24.88K
Volume
132.38K
P/E ratio
129.05
52-wk high
$2.94
52-wk low
$0.98
EPS
$0.02
Beta
0.60
Shares outstanding
11.57M
No. of employees
1
Open
$2.01
High
$2.02
Low
$1.94
Mkt. cap
23.03M
Avg. vol.
24.88K
Volume
132.38K
P/E ratio
129.05
52-wk high
$2.94
52-wk low
$0.98
EPS
$0.02
Beta
0.60
Shares outstanding
11.57M
No. of employees
1
News stories
From sources across the web
About TherapeuticsMD Inc
CEO-
Employees1
Founded1907
HeadquartersBoca Raton, Florida, United States
SectorPharmaceutical industry
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.01 / -
0.00%miss
Revenue / Est. (USD)
724.00K / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
952.00K
784.00K
893.00K
724.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.18M
984.00K
1.76M
836.00K
Operating expense
1.27M
1.08M
1.86M
930.00K
Total operating expenses
1.27M
1.08M
1.86M
930.00K
Operating income
-319.00K
-296.00K
-969.00K
-206.00K
Other non operating income
866.00K
381.00K
296.00K
268.00K
EBT including unusual items
545.00K
50.00K
-580.00K
103.00K
EBT excluding unusual items
545.00K
82.00K
-524.00K
103.00K
Income tax expense
-
-
32.00K
-
Effective tax rate
-
-
-5.52%
-
Other operating expenses
-
-
-
-
Net income
551.00K
152.00K
-619.00K
95.00K
Net profit margin
57.88%
19.39%
-69.32%
13.12%
Earnings per share
-
-
-
-
Interest and investment income
-
-
149.00K
-
Interest expense
-2.00K
-3.00K
-
41.00K
Net interest expenses
-2.00K
-3.00K
149.00K
41.00K
Depreciation and amortization charges
96.00K
96.00K
97.00K
94.00K
EBITDA
-223.00K
-200.00K
-872.00K
-112.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more